CX3CL1 and breast cancer: Remarkably, when breast cancer cells were inoculated in transgenic mice knockout for FKN (FKN-/-) via a hematogeneous route, a 70% reduction in the detection of bone disseminated tumor cells (DTC) was observed as compared to FKN-expressing animals.